Global and Region Hospital-Acquired Infections (HAIs) Control Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Hospital-Acquired Infections (HAIs) Control market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital-Acquired Infections (HAIs) Controlmarket, defines the market attractiveness level of Hospital-Acquired Infections (HAIs) Control market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hospital-Acquired Infections (HAIs) Control industry, describes the types of Hospital-Acquired Infections (HAIs) Control market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital-Acquired Infections (HAIs) Control market and the development prospects and opportunities of Hospital-Acquired Infections (HAIs) Control industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital-Acquired Infections (HAIs) Control market in Chapter 13.

    By Player:

    • STERIS Corporation

    • Becton Dickinson

    • Advanced Sterilization Products Division

    • Hoffmann-La Roche

    • Pfizer

    By Type:

    • Diagnostic Techniques

    • Cleaning and Sterilization

    • Treatment

    By End-User:

    • General Hospital

    • Infectious Disease Hospital

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hospital-Acquired Infections (HAIs) Control Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hospital-Acquired Infections (HAIs) Control Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hospital-Acquired Infections (HAIs) Control Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hospital-Acquired Infections (HAIs) Control Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hospital-Acquired Infections (HAIs) Control Market Analysis and Outlook to 2022

    • 7.1 Global Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    • 7.2 United States Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    • 7.3 Europe Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    • 7.4 China Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    • 7.5 Japan Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    • 7.6 India Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    • 7.7 South Korea Hospital-Acquired Infections (HAIs) Control Consumption (2017-2022)

    8 Region and Country-wise Hospital-Acquired Infections (HAIs) Control Market Analysis and Outlook to 2028

    • 8.1 Global Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    • 8.2 United States Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    • 8.3 Europe Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    • 8.4 China Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    • 8.5 Japan Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    • 8.6 India Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    • 8.7 South Korea Hospital-Acquired Infections (HAIs) Control Consumption Forecast (2022-2028)

    9 Global Hospital-Acquired Infections (HAIs) Control Market Outlook by Types and Applications to 2022

    • 9.1 Global Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostic Techniques Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cleaning and Sterilization Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Treatment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global General Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Infectious Disease Hospital Consumption and Growth Rate (2017-2022)

    10 Global Hospital-Acquired Infections (HAIs) Control Market Outlook by Types and Applications to 2028

    • 10.1 Global Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostic Techniques Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cleaning and Sterilization Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Treatment Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global General Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Infectious Disease Hospital Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hospital-Acquired Infections (HAIs) Control Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hospital-Acquired Infections (HAIs) Control Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hospital-Acquired Infections (HAIs) Control Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hospital-Acquired Infections (HAIs) Control Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hospital-Acquired Infections (HAIs) Control Market Competitive Analysis

    • 14.1 STERIS Corporation

      • 14.1.1 STERIS Corporation Company Details

      • 14.1.2 STERIS Corporation Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 STERIS Corporation Hospital-Acquired Infections (HAIs) Control Product and Service

    • 14.2 Becton Dickinson

      • 14.2.1 Becton Dickinson Company Details

      • 14.2.2 Becton Dickinson Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Becton Dickinson Hospital-Acquired Infections (HAIs) Control Product and Service

    • 14.3 Advanced Sterilization Products Division

      • 14.3.1 Advanced Sterilization Products Division Company Details

      • 14.3.2 Advanced Sterilization Products Division Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Advanced Sterilization Products Division Hospital-Acquired Infections (HAIs) Control Product and Service

    • 14.4 Hoffmann-La Roche

      • 14.4.1 Hoffmann-La Roche Company Details

      • 14.4.2 Hoffmann-La Roche Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hoffmann-La Roche Hospital-Acquired Infections (HAIs) Control Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Hospital-Acquired Infections (HAIs) Control Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hospital-Acquired Infections (HAIs) Control

    • Figure Hospital-Acquired Infections (HAIs) Control Picture

    • Table Global Hospital-Acquired Infections (HAIs) Control Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital-Acquired Infections (HAIs) Control Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hospital-Acquired Infections (HAIs) Control Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hospital-Acquired Infections (HAIs) Control Consumption by Country (2017-2022)

    • Figure United States Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate (2017-2022)

    • Table Europe Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate (2017-2022)

    • Figure China Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate (2017-2022)

    • Figure Japan Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate (2017-2022)

    • Figure India Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hospital-Acquired Infections (HAIs) Control Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital-Acquired Infections (HAIs) Control Consumption Forecast by Country (2022-2028)

    • Figure United States Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hospital-Acquired Infections (HAIs) Control Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Techniques Consumption and Growth Rate (2017-2022)

    • Figure Global Cleaning and Sterilization Consumption and Growth Rate (2017-2022)

    • Figure Global Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global General Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Disease Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Techniques Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cleaning and Sterilization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global General Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Disease Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hospital-Acquired Infections (HAIs) Control Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hospital-Acquired Infections (HAIs) Control Export by Region (Top 5 Countries) (2017-2028)

    • Table STERIS Corporation (Foundation Year, Company Profile and etc.)

    • Table STERIS Corporation Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

    • Table STERIS Corporation Hospital-Acquired Infections (HAIs) Control Product and Service

    • Table Becton Dickinson (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Hospital-Acquired Infections (HAIs) Control Product and Service

    • Table Advanced Sterilization Products Division (Foundation Year, Company Profile and etc.)

    • Table Advanced Sterilization Products Division Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Sterilization Products Division Hospital-Acquired Infections (HAIs) Control Product and Service

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Hospital-Acquired Infections (HAIs) Control Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Hospital-Acquired Infections (HAIs) Control Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Hospital-Acquired Infections (HAIs) Control Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.